The common mutation BRAFV600 in primary melanomas activates the mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) pathway and the …
MA Vogelbaum, PD Brown, H Messersmith… - 2022 - academic.oup.com
Purpose To provide guidance to clinicians regarding therapy for patients with brain metastases from solid tumors. Methods ASCO convened an Expert Panel and conducted a …
R Seth, H Messersmith, V Kaur, JM Kirkwood… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide guidance to clinicians regarding the use of systemic therapy for melanoma. METHODS ASCO convened an Expert Panel and conducted a systematic …
R Seth, SS Agarwala, H Messersmith… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To provide guidance to clinicians regarding the use of systemic therapy for melanoma. METHODS American Society of Clinical Oncology convened an Expert Panel …
U Keilholz, PA Ascierto, R Dummer, C Robert… - Annals of oncology, 2020 - Elsevier
Highlights•A melanoma consensus conference, organised by the ESMO Guidelines Committee, was attended by 32 experts from 14 countries•The experts compiled …
Background Melanoma has one of the fastest rising incidence rates of any cancer. It accounts for a small percentage of skin cancer cases but is responsible for the majority of …
MP Johnston, SI Khakoo - World journal of gastroenterology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) arises on the background of chronic liver disease. Despite the development of effective anti-viral therapeutics HCC is continuing to rise, in part driven …
Despite continuous therapeutic progress, cancer remains an often fatal disease. In the early 2010s, first evidence in rodent models suggested promising antitumor action of gas plasma …
Abstract Background The World Health Organization (WHO) and the International Labour Organization (ILO) are developing joint estimates of the work-related burden of disease and …